Phoenix Rising - Scientists resuscitate a 5 million-year-old retrovirus|
VILLEJUIF, France (Tues., Oct. 31, 2006) – A team of scientists has reconstructed the DNA sequence of a 5-million-year-old retrovirus and shown that it is able to produce infectious particles. The retrovirus—named Phoenix—is the ancestor of a large family of mobile DNA elements, some of which may play a role in cancer. The study, which is the first to generate an infectious retrovirus from a mobile element in the human genome, is considered a breakthrough for the field of retrovirus research. The findings are reported in Genome Research.
“Phoenix became frozen in time after it integrated into the human genome about 5 million years ago,” explains Dr. Thierry Heidmann, lead investigator on the project. “In our study, we’ve recovered this ancestral state and shown that it has the potential for infectivity.”
Retroviruses, whose genomes consist of RNA, can create DNA “copies” of the RNA genomes and incorporate them into the genomes of their hosts. Phoenix belongs to a sub-category of retroviruses—known as HERVs (human endogenous retroviruses)—which inserted copies into the human germline millions of years ago. These copies were subsequently passed on from generation to generation. Remnants of HERVs now comprise nearly 8% of the human genome, but most were rendered inactive long ago by mutations.
Heidmann and his colleagues set out to re-activate one family of HERVs, called the HERV-K(HML2) family, an evolutionarily “young” family of retroviral elements. They aligned HERV-K(HML2) elements, determined their consensus sequence, and then constructed a retrovirus—Phoenix—from the consensus sequence by mutating existing HERV-K(HML2) copies.
In addition, the researchers showed that Phoenix could form particles capable of infecting mammalian cells in culture. Infectivity was very low, presumably because host cells have evolved mechanisms to resist uncontrolled virus propagation, as has been repeatedly observed for retroviruses from experimental animals.
“Phoenix has produced some ‘genomic offspring’ that may be responsible for the synthesis of the retroviral particles that can be observed in some human cancers such as germline tumors and melanomas,” says Heidmann. “This work will be helpful in tracking down the role of retroviruses in these human diseases.”
The work was conducted by Heidmann’s group at the Institut Gustave-Roussy in collaboration with Gérard Pierron from the Institut André Lwoff. Dr. Marie Dewannieux, formerly with Heidmann and now a postdoc at the University College of London, is the first author on the paper. The work was funded by the CNRS (Centre National de la Recherche Scientifique), the Institut Gustave Roussy, the Université Paris XI, and the Ligue Nationale contre le Cancer (Equipe Labellisée).
Dr. Thierry Heidmann, lead investigator on the project, has agreed to be contacted by e-mail (email@example.com) for additional information.
Interested reporters may obtain pre-print copies of the manuscript from Peggy Calicchia, Editorial Secretary, Genome Research (firstname.lastname@example.org). The manuscript, entitled “Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements,” will be published in the December issue (volume 16, issue 12) of Genome Research and will appear online (DOI: 10.1101/gr.5565706) after October 30, 2006.
Genome Research (www.genome.org) is an international, continuously published, peer-reviewed journal published by Cold Spring Harbor Laboratory Press. Launched in 1995, it is one of the five most highly cited primary research journals in genetics and genomics.
Cold Spring Harbor Laboratory Press is an internationally renowned publisher of books, journals, and electronic media, located on Long Island, New York. It is a division of Cold Spring Harbor Laboratory, an innovator in life science research and the education of scientists, students, and the public. For more information, visit www.cshlpress.com.
Genome Research issues press releases to highlight significant research studies that are published in the journal.